CoChat

Malignant Pleural Mesothelioma: Current Understanding of the Immune Microenvironment and Treatments of a Rare Disease

Open access
Tedesco, John, Jaradeh, Mark, Vigneswaran, Wickii T. · 2022 · Cancers

The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.

Abstract

Malignant pleural mesothelioma is a rare disease with an annual incidence of around 3000 cases a year in the United States. Most cases are caused by asbestos exposure, with a latency period of up to 40 years. Pleural mesothelioma is an aggressive disease process with overall survival of roughly 6-12 months after the time of diagnosis. It is divided into three subtypes: epithelioid, mixed type, and sarcomatoid type, with the epithelioid subtype having the best overall survival. Often, the treatment is multimodality with surgery, chemotherapy, and radiation. The survival benefit is improved but remains marginal. New treatment options involving targeted immune therapies appear to offer some promise. The tumor microenvironment is the ecosystem within the tumor that interacts and influences the host immune system. Understanding this complex interaction and how the host immune system is involved in the progression of the disease process is important to define and guide potential treatment options for this devastating and rare disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers14184415

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Current treatment algorithm for malignant mesothelioma. EPP, extrapleural pneumonectomy; PD, pleurectomy with decortication.
Figure 1 Current treatment algorithm for malignant mesothelioma. EPP, extrapleural pneumonectomy; PD, pleurectomy with decortication.CC BY · PubMed Central
Figure 2 Bar graph depicting the proportion of samples studied by Bueno et al. found to have significant mutations in the corresponding gene (n = 202, * N = 99).
Figure 2 Bar graph depicting the proportion of samples studied by Bueno et al. found to have significant mutations in the corresponding gene (n = 202, * N = 99).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 1

  1. Sugarbaker D. Bueno R. Burt B.M. Groth S.S. Loor G. Wolf A.S. Sugarbaker’s Adult Chest Surgery 3rd ed. McGraw Hill/Medical New York, NY, USA 2020

Cited by

See all 12

Metadata

Authors
Tedesco, J., Jaradeh, M., & Vigneswaran, W. T.
Affiliations
Loyola University Medical Center (US)
Corresponding author
Vigneswaran, Wickii T.
Venue
Cancers
Publisher
MDPI AG
Published
2022-09-11
Volume
14
Issue
18
Pages
4415
ISSN
2072-6694 (ISSN-L)
OpenAlex
W4295560430
Cited by
12
References
25
Citations by year
2026: 2 · 2025: 2 · 2024: 6 · 2023: 2
FWCI
1.61
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
malignant pleural mesothelioma, tumor immune microenvironment, asbestos exposure, epithelioid subtype, multimodal therapy, chemotherapy, radiotherapy, rare tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Malignant Pleural Mesothelioma: Current Understanding of the Immune Microenvironment and Treatments of a Rare Disease. https://app.cochat.ai/papers/10.3390/cancers14184415
The paper
Tedesco, J., Jaradeh, M., & Vigneswaran, W. T. (2022). Malignant Pleural Mesothelioma: Current Understanding of the Immune Microenvironment and Treatments of a Rare Disease. Cancers. https://doi.org/10.3390/cancers14184415

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.